Houlihan Lokey announced that Sherman Guillema has joined the firm’s Financial Sponsors Group as a Managing Director. Guillema is based in Dallas and will further strengthen the firm’s coverage ...
Knight Therapeutics, a pan-American (ex-US) specialty pharmaceutical company, closed the syndication of its US$100 million secured revolving credit facility. On June 17, 2025, Knight had announced ...